Abstract:Background: Triple-negative breast cancer (TNBC) is the most heterogenous and aggressive subtype of breast cancer. Chemotherapy remains the standard treatment option for patients with TNBC owing to the unavailability of acceptable targets and biomarkers in clinical practice. Novel biomarkers and targets for patient stratification and treatment of TNBC are urgently needed. It has been reported that the overexpression of DNA damage-inducible transcript 4 gene (DDIT4) is associated with resistance to neoadjuvant chemotherapy and poor prognosis in patients with TNBC. In this study, we aimed to identify novel biomarkers and therapeutic targets using RNA sequencing (RNA-seq) and data mining using data from public databases. Methods: RNA sequencing (RNA-Seq) was performed to detect the different gene expression patterns in the human TNBC cell line HS578T treated with docetaxel or doxorubicin. Sequencing data were further analyzed by the R package "edgeR" and "clusterProfiler" to identify the profile of differentially expressed genes (DEGs) and annotate gene functions. The prognostic and predictive value of DDIT4 expression in patients with TNBC was further validated by published online data resources, including TIMER, UALCAN, Kaplan-Meier plotter, and LinkedOmics, and GeneMANIA and GSCALite were used to investigate the functional networks and hub genes related to DDIT4, respectively. Results: Through the integrative analyses of RNA-Seq data and public datasets, we observed the overexpression of DDIT4 in TNBC tissues and found that patients with DDIT4 overexpression showed poor survival outcomes. Notably, immune infiltration analysis showed that the levels of DDIT4 expression correlated negatively with the abundance of tumor-infiltrating immune cells and immune biomarker expression, but correlated positively with immune checkpoint molecules. Furthermore, DDIT4 and its hub genes (ADM, ENO1, PLOD1, and CEBPB) involved in the activation of apoptosis, cell cycle, and EMT pathways. Eventually, we found ADM, ENO1, PLOD1, and CEBPB showed poor overall survival in BC patients. Conclusion: In this study, we found that DDIT4 expression is associated with the progression, therapeutic efficacy, and immune microenvironment of patients with TNBC, and DDIT4 would be as a potential prognostic biomarker and therapeutic target. These findings will help to identify potential molecular targets and improve therapeutic strategies against TNBC.

DDIT3 and KAT2A Proteins Regulate TNFRSF10A and TNFRSF10B Expression in Endoplasmic Reticulum Stress-mediated Apoptosis in Human Lung Cancer Cells*

AIP1 Recruits Phosphatase PP2A to ASK1 in Tumor Necrosis Factor–Induced ASK1-JNK Activation

STAT1 Mediates Transmembrane TNF-alpha-induced Formation of Death-Inducing Signaling Complex and Apoptotic Signaling Via TNFR1.

DAPK Mediates TNF‐alpha Induced Apoptosis by TNF‐receptor 1 Association and JNK Activation Through MKK7

Death Receptor 3 Mediates TNFSF15- and TNFα-induced Endothelial Cell Apoptosis

Endoplasmic reticulum stress regulates apoptosis and chemotherapeutic via enhancing TNFRSF10B recycling to the cell membrane in triple-negative breast cancer

Both Internalization and AIP1 Association Are Required for Tumor Necrosis Factor Receptor 2-Mediated JNK Signaling.

DDIT3 is associated with breast cancer prognosis and immune microenvironment: an integrative bioinformatic and immunohistochemical analysis

Phospho-Sxxe/D Motif Mediated Tnf Receptor 1-Tradd Death Domain Complex Formation For T Cell Activation And Migration

Attenuation of TNFSF10/TRAIL-induced apoptosis by an autophagic survival pathway involving TRAF2- and RIPK1/RIP1-mediated MAPK8/JNK activation

Tumor Necrosis Factor (TNF) Receptor Expression Determines Keratinocyte Fate Upon Stimulation with TNF-Like Weak Inducer of Apoptosis

DNA damage-inducible transcript 3 positively regulates RIPK1-mediated necroptosis

Differential Regulation Of The Expression Of Cd95 Ligand, Receptor Activator Of Nuclear Factor-Kappa B Ligand (Rankl), Tnf-Related Apoptosis-Inducing Ligand (Trail), And Tnf-Alpha During T Cell Activation

Role of ATF3 in Synergistic Cancer Cell Killing by a Combination of HDAC Inhibitors and Agonistic Anti-Dr5 Antibody Through ER Stress in Human Colon Cancer Cells

Identification of the Distinct Promoters for the Two Transcripts of Apoptosis Related Protein 3 and Their Transcriptional Regulation by Nfat and Nf Kappa B

ATF3 Repression of BCL-XL Determines Apoptotic Sensitivity to HDAC Inhibitors across Tumor Types

Docetaxel-triggered SIDT2/NOX4/JNK/HuR signaling axis is associated with TNF-α-mediated apoptosis of cancer cells

Bcl-3 Promotes TNF-induced Hepatocyte Apoptosis by Regulating the Deubiquitination of RIP1

Identification of DDIT4 as a potential prognostic marker associated with chemotherapeutic and immunotherapeutic response in triple-negative breast cancer

Involvement of adaptor protein, phosphotyrosine interacting with PH domain and leucine zipper 1 in diallyl trisulfide-induced cytotoxicity in hepatocellular carcinoma cells.

Tumor Protein p63/Nuclear Factor κB Feedback Loop in Regulation of Cell Death